Disclaimer This document is published by the World Economic Forum as a contribution to a
project, insight area or interaction. The findings, interpretations and conclusions expressed …

Background Small-cell lung cancer (SCLC) is an aggressive, rapidly progressive
malignancy. Thus, expedient diagnosis and treatment initiation is important. This study …

Patients' insights into the factors affecting access, referral and treatment of lung cancer in
public healthcare facilities, are key to the fight against this disease. On the other hand, the …

Background: The relationship between the provision of timely treatment to lung cancer
patients with chronic diseases and their survival rate has not been previously examined …

Purpose: The topic of providing timely treatment to lung cancer patients with chronic
diseases has not been widely examined. This study therefore aimed to investigate the …

Introducción: la presentación tardía de síntomas relacionados con el cáncer de pulmón (CP)
y la demora en consultar es frecuente. Objetivo: conocer los síntomas referidos por los …

Background Delays in care negatively affect patients with potentially resectable thoracic
malignant diseases. The Alberta Thoracic Oncology Program established an automatic …

Lung cancer (LC) is the leading cause of cancer incidence and mortality in men and women
globally, with 2.1 million new cases and 1.8 million deaths in 2018 (Bray et al., 2018). It is …

Objectives: To investigate the time to treatment among LA NSCLC patients, assess risk
factors for delayed treatment, and evaluate its impact on cancer-specific survival. Method …

Cancer incidence and outcomes vary across populations and geographies over time.
Understanding the extent and causes of disparities is essential to cancer control. This thesis …